E1LV34 Stock Overview
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Elevance Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$499.00 |
| 52 Week High | US$499.00 |
| 52 Week Low | US$422.69 |
| Beta | 0.81 |
| 1 Month Change | 0% |
| 3 Month Change | 7.57% |
| 1 Year Change | n/a |
| 3 Year Change | 21.41% |
| 5 Year Change | n/a |
| Change since IPO | 108.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| E1LV34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | 0% | 3.8% | 0.4% |
| 1Y | n/a | 3.9% | 13.9% |
Return vs Industry: Insufficient data to determine how E1LV34 performed against the BR Healthcare industry.
Return vs Market: Insufficient data to determine how E1LV34 performed against the BR Market.
Price Volatility
| E1LV34 volatility | |
|---|---|
| E1LV34 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.7% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in BR Market | 8.8% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: E1LV34 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine E1LV34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 104,900 | Gail Boudreaux | www.elevancehealth.com |
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Elevance Health, Inc. Fundamentals Summary
| E1LV34 fundamental statistics | |
|---|---|
| Market cap | R$638.54b |
| Earnings (TTM) | R$32.14b |
| Revenue (TTM) | R$884.06b |
19.9x
P/E Ratio0.7x
P/S RatioIs E1LV34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| E1LV34 income statement (TTM) | |
|---|---|
| Revenue | US$171.75b |
| Cost of Revenue | US$124.09b |
| Gross Profit | US$47.66b |
| Other Expenses | US$41.41b |
| Earnings | US$6.24b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 26.87 |
| Gross Margin | 27.75% |
| Net Profit Margin | 3.64% |
| Debt/Equity Ratio | 65.0% |
How did E1LV34 perform over the long term?
See historical performance and comparison